LIGAND PHARMACEUTICALS INCORPORATED Adjustments to Additional Paid in Capital, Other
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Adjustments to Additional Paid in Capital, Other of -$1.36 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2023-02-28
- LIGAND PHARMACEUTICALS INCORPORATED adjustments to additional paid in capital, other for the quarter ending 2021-06-30 was -$1.36M.
- LIGAND PHARMACEUTICALS INCORPORATED adjustments to additional paid in capital, other for the quarter ending 2020-06-30 was -$23.00K, a 100.98% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED adjustments to additional paid in capital, other for the quarter ending 2020-03-31 was -$2.75M.
- LIGAND PHARMACEUTICALS INCORPORATED adjustments to additional paid in capital, other for the quarter ending 2019-09-30 was $22.00K.
- LIGAND PHARMACEUTICALS INCORPORATED adjustments to additional paid in capital, other for fiscal 2020 was $3.00K, a 99.81% decline from fiscal 2019.
- LIGAND PHARMACEUTICALS INCORPORATED adjustments to additional paid in capital, other for fiscal 2019 was $1.55M, a 347.11% increase from fiscal 2018.
- LIGAND PHARMACEUTICALS INCORPORATED adjustments to additional paid in capital, other for fiscal 2018 was $346.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$1.36M 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $3.00K 10-K · filed 2023-02-28 | |||
| 2020-06-30 | -$23.00K 10-Q · filed 2021-11-09 | -$2.77M derived: sum of 2 quarters · filed 2021-11-09 | ||
| 2020-03-31 | -$2.75M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $1.55M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $22.00K 10-Q · filed 2020-11-06 | $2.37M derived: sum of 2 quarters · filed 2020-11-06 | $1.80M derived: sum of 3 quarters · filed 2020-11-06 | |
| 2019-06-30 | $2.34M 10-Q · filed 2020-11-06 | $1.77M derived: sum of 2 quarters · filed 2020-11-06 | ||
| 2019-03-31 | -$569.00K 10-Q · filed 2020-11-06 | |||
| 2018-12-31 | $346.00K 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | $838.00K derived: sum of 2 quarters · filed 2019-11-08 | ||
| 2018-06-30 | $838.00K 10-Q · filed 2019-11-08 |